S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis.

Zi-Xuan Wu Dongli Jiang Xuyan Huang Minjie Cai Kai Yuan Peidong Huang

Published in: Journal of oncology (2022)

S100A8 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., GBM, KIRC, LGG, and LIHC).

Keyphrases

endothelial cells
induced pluripotent stem cells
pluripotent stem cells
protein protein
network analysis